Navigation Links
Scientists ID Enzyme That Allows Dysentery Amoeba to Hide
Date:6/19/2008

Finding could lead to more effective treatments for diarrhea worldwide, study says

THURSDAY, June 19 (HealthDay News) U.S. researchers say they've identified an enzyme that may help dysentery-causing amoeba evade the immune system.

The finding may help lead to new ways to fight dysentery, a form of diarrhea that affects about 500 million people worldwide each year and is a serious health threat in many regions.

"This is the first enzyme to be identified that looks like it could mediate immune system evasion," Sin Urban, an assistant professor of molecular biology and genetics at Johns Hopkins University, Baltimore, said in a prepared statement.

Urban and colleagues found the EhROM1 enzyme in the dysentery-causing amoeba Entamoeba histolytica.

The study was published in the June 15 issue of the journal Genes & Development.

The EhROM1 enzyme is part of an ancient group of enzymes known as rhomboid enzymes. In most animals, these enzymes play a role in cell-to-cell communication. But a few years ago, Urban found that malaria parasites use rhomboid enzymes to invade host cells.

This led him to look at the DNA of other disease-causing organisms to see if any of them also had genes that encode rhomboid enzymes. That led to the discovery of EhROM1 in Entamoeba histolytica. More research is needed to determine exactly how it helps this amoeba evade detection by the immune system.

The EhROM1 enzyme is similar to those found in malaria parasites, which suggests that a drug that targets EhROM1 in order to treat dysentery might also prove effective against malaria, Urban said.

More information

The U.S. Centers for Disease Control and Prevention has more about chronic diarrhea.



-- Robert Preidt



SOURCE: Johns Hopkins Medicine, news release, June 14, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Neuroscientists show insulin receptor signaling regulates structure of brain circuits
2. UF scientists to work with German firm in prostate cancer treatment research
3. Scientists from Granada drastically reduce the wait time for new teeth implant
4. Possible link between different forms of epilepsy found by Carnegie Mellon scientists
5. Scientists Discover Protein Involved in Fat Production
6. Twenty of Americas Most Promising Scientists Selected as 2008 Pew Scholars in the Biomedical Sciences
7. QBI neuroscientists make Alzheimers disease advance
8. EPA scientists recognized with prestigious honor
9. 2collab Survey Reveals That Scientists and Researchers are "All Business" With Social Applications
10. Scientists ID Brain Pathway That Stops Seizures
11. Scientists ID Gene Regulating Blood Glucose Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment ... Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... General Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... June 23, 2016  Experian Health, the ... transforming the patient payment and care experience, ... new products and services that will enhance ... cycle offerings. These award-winning solutions will enable ... remain compliant in an ever-changing environment and ...
Breaking Medicine Technology: